Association of SGLT2 inhibitors with cardiovascular, kidney, and safety outcomes among patients with diabetic kidney disease: a meta-analysis

BACKGROUND: We conducted a systematic review and meta-analysis of the cardiovascular, kidney, and safety outcomes of sodium-glucose cotransporter 2 inhibitors (SGLT2i) among patients with diabetic kidney disease (DKD). METHODS: We searched electronic databases for major randomized placebo-controlled...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaze, Arnaud D., Zhuo, Min, Kim, Seoyoung C., Patorno, Elisabetta, Paik, Julie M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491404/
https://www.ncbi.nlm.nih.gov/pubmed/35321742
http://dx.doi.org/10.1186/s12933-022-01476-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491404/
https://www.ncbi.nlm.nih.gov/pubmed/35321742
http://dx.doi.org/10.1186/s12933-022-01476-x

Ejemplares similares